Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,630 total articles
Mama's Creations, a fresh deli prepared foods company, reported a 55% revenue increase to $54.6 million and net income doubling to $2.6 million in Q2 fiscal 2027. Adjusted EBITDA grew by nearly 69%, driven by new product launches, expanded retailer placements including Costco and Kroger, and operational leverage improvements. The company raised $10…
Spyre Therapeutics, a clinical-stage biotechnology company specializing in immunology therapies, announced its management team's participation in several upcoming investor conferences in September 2026. The company aims to update investors on its pipeline developments and strategic initiatives, including investigational extended half-life antibodie…
BioStem Technologies Inc., a regenerative medicine company specializing in perinatal tissue allograft products, announced its management will present at the H.C. Wainwright Global Investment Conference. The presentation will provide updates on its proprietary technologies, product portfolio, and clinical research initiatives.
Wave Life Sciences announced that its President and CEO, Paul Bolno, MD, MBA, will participate in an analyst-led fireside chat at the Cantor 2026 Global Healthcare Conference. The event will showcase the company's RNA medicines platform and pipeline progress, including therapies targeting obesity, alpha-1 antitrypsin deficiency, liver disease, Duch…
Ambarella, Inc. announced financial results for Q2 fiscal 2027, showing 13.2% revenue growth year-over-year to $108.1 million and significant reduction in GAAP net loss. Non-GAAP net income increased to $8.2 million from $6.4 million a year ago. The company highlighted record edge AI revenue driven by 5nm AI SoCs and new go-to-market strategies inc…
Navitas Semiconductor announced its participation in the Citi 2026 Global TMT Conference on September 8, 2026, where top executives will host a fireside chat and meet with investors to discuss its innovative GaNFast and GeneSiC power semiconductor products. The company emphasizes its leadership in GaN and SiC technologies that drive efficiency and …
Nasdaq announced its monthly trading volumes for August 2026, available on its Investor Relations website. The update highlights market activity but contains no new strategic developments or financial results.
Oxford Industries announced its second quarter fiscal 2026 results showing a 2.2% decline in consolidated net sales to $394 million and adjusted EPS growth to $1.34 from $1.26 last year, boosted by a $2.07 per share tariff refund. Tommy Bahama sales grew slightly, while Lilly Pulitzer and Johnny Was experienced declines, prompting the company to lo…
Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) announced strong Q3 fiscal 2026 results with 13% revenue growth to $116.8 million and a 17% increase in income from operations. Adjusted EBITDA rose 13% to $30.4 million. The company raised its full-year guidance, extended its share repurchase program, and initiated a quarterly cash dividend yielding 5…
Pasithea Therapeutics Corp., a clinical-stage biotech company developing PAS-004, a next-gen MEK inhibitor for diseases including neurofibromatosis type 1, announced its management team's participation in the 12th Annual Cantor Global Healthcare Conference and the H.C. Wainwright 28th Annual Global Investment Conference in September 2026. The compa…
Ambarella, a leading edge AI semiconductor company, has engaged Capgemini to help speed the development and deployment of Edge and Physical AI solutions across multiple sectors including smart infrastructure, retail, logistics, industrial automation, healthcare, and automotive. Capgemini will provide engineering, systems integration, and industry e…
Connect Biopharma, a clinical-stage biopharmaceutical company focused on treatments for inflammatory diseases such as asthma and COPD, announced its participation in the H.C. Wainwright Annual Global Investment Conference. The company is advancing rademikibart, a next-generation antibody targeting IL-4Rα, currently in global clinical trials for ast…
Agomab Therapeutics NV, a clinical-stage biopharmaceutical company focused on fibro-inflammatory diseases, announced that its management team will participate in several prominent investor conferences in September 2026, including Citi's Biopharma Back to School, Cantor Global Healthcare, H.C. Wainwright Global Investment, and Morgan Stanley Global …
Spero Therapeutics, a clinical-stage biopharmaceutical company listed on Nasdaq, announced inducement grants of restricted stock units and stock options to new employees under Nasdaq listing rule 5635(c)(4). These equity awards are intended as material incentives to attract new talent and will vest over several years, contingent on continued employ…
eGain Corporation announced its fiscal 2026 financial results, highlighting a 3% increase in total revenue to $91.1 million and a 20% growth in AI customer revenue, representing 72% of total SaaS Annual Recurring Revenue (ARR). The company was recognized as a Leader in Gartner's inaugural Customer Service Knowledge Management Magic Quadrant. Despit…
XPO, Inc., a leading North American less-than-truckload (LTL) freight transportation provider, announced preliminary operating metrics for August 2026, showing a 3.7% increase in LTL tonnage per day compared to August 2025. This growth was primarily driven by a 5.7% rise in shipments per day, partially offset by a 1.8% decrease in weight per shipme…
Latigo Biotherapeutics announced its second quarter 2026 results along with key business milestones including an upsized IPO that raised $397.4 million gross proceeds, publication of positive Phase 2 trial results of onzotrigine in The New England Journal of Medicine, and initiation of Phase 3 clinical trials. The company also appointed Naomi Lowy,…
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, announced it will present at the Wells Fargo Healthcare Conference on September 9, 2026. The company focuses on developing treatments for neurological conditions including epilepsy, depression, and pain with promising drug candidates in late-stage and early-stage clinical…
Rein Therapeutics announced that its CEO, Brian Windsor, will present at two key investor conferences in September 2026: the Cantor Global Healthcare Conference and the H.C. Wainwright 28th Annual Global Investment Conference. The company focuses on developing first-in-class therapies for orphan pulmonary and fibrosis diseases, with its lead produc…
Arvinas, Inc., a clinical-stage biotechnology company focusing on targeted protein degradation therapies, announced that its management team will participate in several upcoming investor conferences, including those hosted by Wells Fargo, Cantor, and Morgan Stanley. The company highlights its PROTAC platform and ongoing clinical programs targeting …
Frequency Electronics, Inc. announced it will hold a conference call to discuss its first quarter fiscal 2027 financial results on September 10, 2026. The company specializes in high precision timing, frequency generation, and RF control products used in space, military, and commercial applications.
IDT Corporation announced the introduction of eSIM data plans on its BOSS Revolution app, enabling international travelers to access affordable and high-speed mobile data in more than 190 countries. This service eliminates the need for physical SIM cards and offers significant cost savings on roaming, with plans tailored for different travel durati…
Cricut, Inc. has introduced the Cricut Maker 5, marking its most versatile smart cutting machine to date. The new model supports cutting and engraving on materials up to 3 mm thick—25% more than the previous generation—enabling users to create projects with greater depth and variety, including leather, metal, and acrylic. The device is 30% more com…
Progyny, Inc., a leading women's health and family building solutions provider, announced that CFO Mark Livingston will present at the Wells Fargo 21st Annual Healthcare Conference. The company highlights its comprehensive fertility and women's health benefits solutions designed to optimize clinical outcomes and reduce healthcare costs.
Vishay Intertechnology introduced the CHEP series of thin film chip resistors that deliver superior power handling and high-frequency performance in standard 0402 and 0603 surface-mount footprints. These resistors offer up to 1.8W and 2.8W power handling in small sizes, support wide frequency ranges up to 50 GHz, and are designed to reduce internal…
